Publication | Closed Access

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

Antimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsMedicinePharmacologyPhase 1Antibiotic-associated DiarrheaAntimicrobial PharmacokineticsInfection ControlAntimicrobial PharmacodynamicsMicrobiologyBacterial PathogensClostridium Difficile-associated DiseaseClinical MicrobiologyAntimicrobial Resistance